TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.9891
+0.1143 (13.07%)
At close: May 1, 2026, 4:00 PM EDT
0.9259
-0.0632 (-6.39%)
After-hours: May 1, 2026, 5:10 PM EDT
TELA Bio Revenue
In the year 2025, TELA Bio had annual revenue of $80.28M with 15.84% growth. TELA Bio had revenue of $20.87M in the quarter ending December 31, 2025, with 18.24% growth.
Revenue (ttm)
$80.28M
Revenue Growth
+15.84%
P/S Ratio
0.61
Revenue / Employee
$384,091
Employees
209
Market Cap
44.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 80.28M | 10.98M | 15.84% |
| Dec 31, 2024 | 69.30M | 10.85M | 18.56% |
| Dec 31, 2023 | 58.45M | 17.04M | 41.13% |
| Dec 31, 2022 | 41.42M | 11.96M | 40.58% |
| Dec 31, 2021 | 29.46M | 11.25M | 61.77% |
| Dec 31, 2020 | 18.21M | 2.77M | 17.91% |
| Dec 31, 2019 | 15.45M | 7.17M | 86.68% |
| Dec 31, 2018 | 8.27M | 4.03M | 94.91% |
| Dec 31, 2017 | 4.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 118.37M |
| Pulmonx | 90.50M |
| Myomo | 40.93M |
| Cytosorbents | 37.06M |
| electroCore | 32.03M |
| Elutia | 12.29M |
| NeuroOne Medical Technologies | 11.72M |
TELA News
- 1 day ago - TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues - GlobeNewsWire
- 10 days ago - TELA Bio to Announce First Quarter 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga
- 5 weeks ago - TELA Bio Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - TELA Bio Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts